As of 2026-02-15, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is -0.09 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Revive Therapeutics Ltd is -961.72%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Revive Therapeutics Ltd (RVV.CN) is overvalued by 961.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.09 - -0.09 | -0.09 | -961.72% |
| P/E | (0.28) - (0.41) | (0.34) | -3538.3% |
| DDM - Stable | (0.19) - (0.94) | (0.57) | -5776.1% |
| DDM - Multi | (0.00) - (0.01) | (0.00) | -148.4% |
| Market Cap (mil) | 6.28 |
| Beta | -0.00 |
| Outstanding shares (mil) | 627.85 |
| Enterprise Value (mil) | 6.33 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.99% |
| Cost of Debt | 5.00% |
| WACC | 7.95% |